본문 바로가기 주메뉴 바로가기

인류의 건강과 생명공학 발전을 위해 봉사하는 기업 드림셀

We Serving the Health and Biotechnology of Humanity

제품정보

홈 > 제품정보 > 시약 > 해외 공식 대리점 > [ioEA1093] ioAstrocytes
제품명

[ioEA1093] ioAstrocytes

제품코드 : ioEA1093

제품정보 : ioAstrocytes

  • Cryopreserved human iPSC-derived cells powered by opti-ox, that are ready for experiments in days
  • Functional human astrocytes for neurodegenerative disease modelling, neuroinflammation and drug discovery
  • Perform key astrocytic functions including phagocytosis, cytokine secretion and modulation of neuronal activity in co-culture

제품문의

  • 전화번호
    2292-8870

제품상세

https://www.bit.bio/products/glial-cells/astrocytes-wild-type-io1093?tab=product-overview


Human iPSC-derived astrocytes


ioAstrocytes are functional human iPSC-derived astrocytes, deterministically programmed using opti-ox technology that convert consistently into defined astrocytes within days. Cells demonstrate expected stellate morphology, express key astrocytic markers (SOX9, EAAT1, S100B and Vimentin), are capable of phagocytosis, cytokine secretion, and modulation of neuronal activity in co-culture.


Early access product now available, contact us for more information.


ioAstrocytes are designed for ease of use, delivered cryopreserved and supported by open-source media and protocols to be cultured with other CNS cell types such as ioGlutamatergic Neurons. 


The cells recapitulate key human astrocytic functions, including mediating an inflammatory response, disposal of unwanted materials and modulation of neuronal activity in co-cultures. Multiple lots of cells were investigated by bulk-RNA sequencing, each displaying highly equivalent transcriptomic profiles, with less then 0.5% differentially expressed genes, enabling scientists to generate reproducible data, consistently. 


ioAstrocytes bridge translational gaps and overcome limitations associated with the generation of accurate in vitro models of the human brain, to support neurodegenerative disease research and therapeutic development.


Applications: Neurodegenerative disease modelling, Drug screening & development, Neuropharmacology, Neuroinflammation research, Biomarker discovery